Bank of New York Mellon Corp - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 63 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$20,163
+8.9%
12,6810.0%0.00%
Q4 2022$18,514
-65.7%
12,681
-0.4%
0.00%
Q3 2022$54,000
+10.2%
12,7270.0%0.00%
Q2 2022$49,000
-90.6%
12,727
-88.3%
0.00%
Q1 2022$520,000
+29.4%
109,215
-0.7%
0.00%
Q4 2021$402,000
-53.6%
110,013
+1.9%
0.00%
Q3 2021$866,000
-22.3%
107,938
+9.8%
0.00%
Q2 2021$1,115,00098,2950.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$717,2970.22%
Aisling Capital Management LP 288,571$300,1140.12%
BVF INC/IL 3,614,662$3,759,2480.10%
TRUST CO OF TOLEDO NA /OH/ 33,213$34,5420.01%
MAI Capital Management 397,670$413,5770.01%
Laurion Capital Management LP 698,000$725,9200.00%
RP Management, LLC 3,700$3,8480.00%
UNITED BANK 20,000$20,8000.00%
BOURGEON CAPITAL MANAGEMENT LLC 7,500$7,8000.00%
XTX Topco Ltd 12,084$12,5670.00%
View complete list of VIRACTA THERAPEUTICS INC shareholders